nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSV—corneal epithelium—glaucoma	0.0607	0.42	CbGeAlD
Boceprevir—CYP3A5—Clonidine—glaucoma	0.0454	0.172	CbGbCtD
Boceprevir—CTSV—cornea—glaucoma	0.0442	0.306	CbGeAlD
Boceprevir—CYP3A4—Pilocarpine—glaucoma	0.0363	0.137	CbGbCtD
Boceprevir—ABCB1—Timolol—glaucoma	0.0348	0.132	CbGbCtD
Boceprevir—ABCB1—Clonidine—glaucoma	0.0296	0.112	CbGbCtD
Boceprevir—CYP3A4—Brinzolamide—glaucoma	0.0285	0.108	CbGbCtD
Boceprevir—CYP3A4—Dorzolamide—glaucoma	0.0275	0.104	CbGbCtD
Boceprevir—CYP3A4—Methazolamide—glaucoma	0.0245	0.0929	CbGbCtD
Boceprevir—CYP3A4—Acetazolamide—glaucoma	0.0196	0.0742	CbGbCtD
Boceprevir—CYP3A4—Clonidine—glaucoma	0.0177	0.0671	CbGbCtD
Boceprevir—CTSV—eye—glaucoma	0.00545	0.0377	CbGeAlD
Boceprevir—CMA1—connective tissue—glaucoma	0.00502	0.0346	CbGeAlD
Boceprevir—CTSL—eye—glaucoma	0.00445	0.0308	CbGeAlD
Boceprevir—CTSL—retina—glaucoma	0.00441	0.0305	CbGeAlD
Boceprevir—CTSL—connective tissue—glaucoma	0.00429	0.0296	CbGeAlD
Boceprevir—CTSK—eye—glaucoma	0.00335	0.0232	CbGeAlD
Boceprevir—CTSK—retina—glaucoma	0.00332	0.023	CbGeAlD
Boceprevir—CTSK—connective tissue—glaucoma	0.00323	0.0223	CbGeAlD
Boceprevir—CTSS—retina—glaucoma	0.00291	0.0201	CbGeAlD
Boceprevir—CTSS—connective tissue—glaucoma	0.00283	0.0196	CbGeAlD
Boceprevir—CTSV—Extracellular matrix organization—TGFB2—glaucoma	0.000573	0.00268	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP2—glaucoma	0.000568	0.00266	CbGpPWpGaD
Boceprevir—CYP3A5—Tamoxifen metabolism—CYP1B1—glaucoma	0.00055	0.00257	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP1—glaucoma	0.000539	0.00252	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—VEGFA—glaucoma	0.000537	0.00251	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TXNIP—glaucoma	0.000533	0.00249	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TXNIP—glaucoma	0.000533	0.00249	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—TGFB2—glaucoma	0.000532	0.00249	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TBK1—glaucoma	0.000523	0.00245	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TBK1—glaucoma	0.000523	0.00245	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CTSA—glaucoma	0.000515	0.00241	CbGpPWpGaD
Boceprevir—ABCB1—retina—glaucoma	0.000514	0.00355	CbGeAlD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP2—glaucoma	0.000506	0.00237	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CTSA—glaucoma	0.000504	0.00236	CbGpPWpGaD
Boceprevir—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000503	0.00235	CbGpPWpGaD
Boceprevir—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000492	0.0023	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—glaucoma	0.000482	0.00225	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—MMP9—glaucoma	0.000481	0.00225	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—MMP9—glaucoma	0.000481	0.00225	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TGFB2—glaucoma	0.000474	0.00222	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ACE2—glaucoma	0.000474	0.00222	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—C1QB—glaucoma	0.000473	0.00221	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—C1QB—glaucoma	0.000473	0.00221	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP9—glaucoma	0.000459	0.00215	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP9—glaucoma	0.000459	0.00215	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—BAD—glaucoma	0.000458	0.00214	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TXNIP—glaucoma	0.000442	0.00207	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TBK1—glaucoma	0.000433	0.00203	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP9—glaucoma	0.000427	0.002	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TXN—glaucoma	0.000422	0.00197	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TXN—glaucoma	0.000422	0.00197	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP2—glaucoma	0.000417	0.00195	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CTSA—glaucoma	0.000415	0.00194	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—C1QB—glaucoma	0.000392	0.00183	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TGFB2—glaucoma	0.000391	0.00183	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP9—glaucoma	0.000381	0.00178	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTSA—glaucoma	0.000369	0.00173	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTSA—glaucoma	0.000369	0.00173	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TXNIP—glaucoma	0.000364	0.0017	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TBK1—glaucoma	0.000357	0.00167	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LRP12—glaucoma	0.000355	0.00166	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TXN—glaucoma	0.000349	0.00163	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP1—glaucoma	0.000331	0.00155	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP1—glaucoma	0.000331	0.00155	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—MMP9—glaucoma	0.000328	0.00154	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—C1QB—glaucoma	0.000323	0.00151	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000319	0.00149	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP9—glaucoma	0.000313	0.00147	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TXNIP—glaucoma	0.000311	0.00145	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TXNIP—glaucoma	0.000311	0.00145	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00031	0.00145	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP1—glaucoma	0.000308	0.00144	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTSA—glaucoma	0.000306	0.00143	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TBK1—glaucoma	0.000305	0.00142	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TBK1—glaucoma	0.000305	0.00142	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—FN1—glaucoma	0.000302	0.00141	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—FN1—glaucoma	0.000302	0.00141	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—MMP9—glaucoma	0.000296	0.00138	CbGpPWpGaD
Boceprevir—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000289	0.00135	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TXN—glaucoma	0.000288	0.00135	CbGpPWpGaD
Boceprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000282	0.00132	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—FN1—glaucoma	0.000281	0.00131	CbGpPWpGaD
Boceprevir—CTSL—Immune System—C1QB—glaucoma	0.000276	0.00129	CbGpPWpGaD
Boceprevir—CTSV—Immune System—C1QB—glaucoma	0.000276	0.00129	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP1—glaucoma	0.000274	0.00128	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TXNIP—glaucoma	0.000257	0.0012	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP2—glaucoma	0.000256	0.0012	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP2—glaucoma	0.000256	0.0012	CbGpPWpGaD
Boceprevir—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000256	0.0012	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—PAX6—glaucoma	0.000253	0.00118	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TBK1—glaucoma	0.000252	0.00118	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTSA—glaucoma	0.000252	0.00118	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—FN1—glaucoma	0.00025	0.00117	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—OPN4—glaucoma	0.000246	0.00115	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TXN—glaucoma	0.000246	0.00115	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TXN—glaucoma	0.000246	0.00115	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP2—glaucoma	0.000238	0.00111	CbGpPWpGaD
Boceprevir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000237	0.00111	CbGpPWpGaD
Boceprevir—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000234	0.0011	CbGpPWpGaD
Boceprevir—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000231	0.00108	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HEYL—glaucoma	0.000229	0.00107	CbGpPWpGaD
Boceprevir—CTSK—Immune System—C1QB—glaucoma	0.000228	0.00107	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP1—glaucoma	0.000226	0.00106	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTGFR—glaucoma	0.000222	0.00104	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP2—glaucoma	0.000212	0.000992	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TXNIP—glaucoma	0.000212	0.000991	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TBK1—glaucoma	0.000208	0.000972	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—FN1—glaucoma	0.000206	0.000964	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TXN—glaucoma	0.000203	0.000951	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP9—glaucoma	0.000192	0.0009	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP9—glaucoma	0.000192	0.0009	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000192	0.0009	CbGpPWpGaD
Boceprevir—CTSS—Immune System—C1QB—glaucoma	0.000188	0.000879	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—C3—glaucoma	0.000184	0.000861	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—C3—glaucoma	0.000184	0.000861	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP9—glaucoma	0.000179	0.000837	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—C3—glaucoma	0.000177	0.000826	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—C3—glaucoma	0.000177	0.000826	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—BCL2L1—glaucoma	0.000176	0.000824	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—BCL2L1—glaucoma	0.000176	0.000824	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP2—glaucoma	0.000175	0.000817	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000174	0.000813	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RPTOR—glaucoma	0.000174	0.000812	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NCK2—glaucoma	0.000168	0.000786	CbGpPWpGaD
Boceprevir—Diarrhoea—Apraclonidine—glaucoma	0.000168	0.000445	CcSEcCtD
Boceprevir—Malaise—Clonidine—glaucoma	0.000168	0.000444	CcSEcCtD
Boceprevir—Mediastinal disorder—Betaxolol—glaucoma	0.000168	0.000444	CcSEcCtD
Boceprevir—CTSS—Immune System—TXN—glaucoma	0.000168	0.000784	CbGpPWpGaD
Boceprevir—Dyspepsia—Pilocarpine—glaucoma	0.000167	0.000443	CcSEcCtD
Boceprevir—Chills—Betaxolol—glaucoma	0.000167	0.000442	CcSEcCtD
Boceprevir—Syncope—Clonidine—glaucoma	0.000167	0.000442	CcSEcCtD
Boceprevir—Arrhythmia—Betaxolol—glaucoma	0.000166	0.00044	CcSEcCtD
Boceprevir—Feeling abnormal—Dorzolamide—glaucoma	0.000166	0.000439	CcSEcCtD
Boceprevir—Decreased appetite—Pilocarpine—glaucoma	0.000165	0.000438	CcSEcCtD
Boceprevir—Feeling abnormal—Travoprost—glaucoma	0.000165	0.000437	CcSEcCtD
Boceprevir—Conjunctivitis—Timolol—glaucoma	0.000165	0.000436	CcSEcCtD
Boceprevir—Gastrointestinal pain—Dorzolamide—glaucoma	0.000164	0.000436	CcSEcCtD
Boceprevir—Alopecia—Betaxolol—glaucoma	0.000164	0.000435	CcSEcCtD
Boceprevir—Palpitations—Clonidine—glaucoma	0.000164	0.000435	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000164	0.000435	CcSEcCtD
Boceprevir—Gastrointestinal pain—Travoprost—glaucoma	0.000164	0.000434	CcSEcCtD
Boceprevir—Loss of consciousness—Clonidine—glaucoma	0.000163	0.000433	CcSEcCtD
Boceprevir—Feeling abnormal—Brinzolamide—glaucoma	0.000163	0.000432	CcSEcCtD
Boceprevir—Mental disorder—Betaxolol—glaucoma	0.000163	0.000432	CcSEcCtD
Boceprevir—Pain—Pilocarpine—glaucoma	0.000163	0.000431	CcSEcCtD
Boceprevir—Constipation—Pilocarpine—glaucoma	0.000163	0.000431	CcSEcCtD
Boceprevir—Cough—Clonidine—glaucoma	0.000162	0.00043	CcSEcCtD
Boceprevir—Dizziness—Apraclonidine—glaucoma	0.000162	0.00043	CcSEcCtD
Boceprevir—Erythema—Betaxolol—glaucoma	0.000162	0.000429	CcSEcCtD
Boceprevir—Malnutrition—Betaxolol—glaucoma	0.000162	0.000429	CcSEcCtD
Boceprevir—Urticaria—Dorzolamide—glaucoma	0.00016	0.000423	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—BAD—glaucoma	0.00016	0.000747	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—BAD—glaucoma	0.00016	0.000747	CbGpPWpGaD
Boceprevir—Epistaxis—Timolol—glaucoma	0.00016	0.000423	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—MMP9—glaucoma	0.000159	0.000746	CbGpPWpGaD
Boceprevir—Abdominal pain—Dorzolamide—glaucoma	0.000159	0.000421	CcSEcCtD
Boceprevir—Body temperature increased—Dorzolamide—glaucoma	0.000159	0.000421	CcSEcCtD
Boceprevir—Sinusitis—Timolol—glaucoma	0.000159	0.000421	CcSEcCtD
Boceprevir—Dysgeusia—Betaxolol—glaucoma	0.000159	0.00042	CcSEcCtD
Boceprevir—Arthralgia—Clonidine—glaucoma	0.000158	0.000419	CcSEcCtD
Boceprevir—Chest pain—Clonidine—glaucoma	0.000158	0.000419	CcSEcCtD
Boceprevir—Abdominal pain—Travoprost—glaucoma	0.000158	0.000419	CcSEcCtD
Boceprevir—Agranulocytosis—Timolol—glaucoma	0.000158	0.000418	CcSEcCtD
Boceprevir—Anxiety—Clonidine—glaucoma	0.000158	0.000418	CcSEcCtD
Boceprevir—Asthenia—Acetazolamide—glaucoma	0.000157	0.000417	CcSEcCtD
Boceprevir—Dizziness—Bimatoprost—glaucoma	0.000157	0.000417	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000157	0.000417	CcSEcCtD
Boceprevir—Urticaria—Brinzolamide—glaucoma	0.000157	0.000416	CcSEcCtD
Boceprevir—Feeling abnormal—Pilocarpine—glaucoma	0.000157	0.000415	CcSEcCtD
Boceprevir—Discomfort—Clonidine—glaucoma	0.000156	0.000414	CcSEcCtD
Boceprevir—Vomiting—Apraclonidine—glaucoma	0.000156	0.000413	CcSEcCtD
Boceprevir—Muscle spasms—Betaxolol—glaucoma	0.000156	0.000412	CcSEcCtD
Boceprevir—Gastrointestinal pain—Pilocarpine—glaucoma	0.000155	0.000412	CcSEcCtD
Boceprevir—Hypersensitivity—Brimonidine—glaucoma	0.000155	0.000411	CcSEcCtD
Boceprevir—Dry mouth—Clonidine—glaucoma	0.000155	0.00041	CcSEcCtD
Boceprevir—Dermatitis—Apraclonidine—glaucoma	0.000155	0.000409	CcSEcCtD
Boceprevir—Headache—Apraclonidine—glaucoma	0.000154	0.000407	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—BAD—glaucoma	0.000153	0.000717	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—BAD—glaucoma	0.000153	0.000717	CbGpPWpGaD
Boceprevir—Confusional state—Clonidine—glaucoma	0.000153	0.000405	CcSEcCtD
Boceprevir—Vision blurred—Betaxolol—glaucoma	0.000153	0.000404	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—C3—glaucoma	0.000152	0.000713	CbGpPWpGaD
Boceprevir—Rhinitis—Timolol—glaucoma	0.000152	0.000404	CcSEcCtD
Boceprevir—Asthenia—Brimonidine—glaucoma	0.000151	0.0004	CcSEcCtD
Boceprevir—Infection—Clonidine—glaucoma	0.000151	0.000399	CcSEcCtD
Boceprevir—Body temperature increased—Pilocarpine—glaucoma	0.00015	0.000398	CcSEcCtD
Boceprevir—Abdominal pain—Pilocarpine—glaucoma	0.00015	0.000398	CcSEcCtD
Boceprevir—Ill-defined disorder—Betaxolol—glaucoma	0.00015	0.000398	CcSEcCtD
Boceprevir—Diarrhoea—Acetazolamide—glaucoma	0.00015	0.000398	CcSEcCtD
Boceprevir—Rash—Bimatoprost—glaucoma	0.00015	0.000397	CcSEcCtD
Boceprevir—Dermatitis—Bimatoprost—glaucoma	0.00015	0.000397	CcSEcCtD
Boceprevir—Oedema peripheral—Timolol—glaucoma	0.00015	0.000397	CcSEcCtD
Boceprevir—Anaemia—Betaxolol—glaucoma	0.00015	0.000396	CcSEcCtD
Boceprevir—Shock—Clonidine—glaucoma	0.000149	0.000396	CcSEcCtD
Boceprevir—Connective tissue disorder—Timolol—glaucoma	0.000149	0.000396	CcSEcCtD
Boceprevir—Pruritus—Brimonidine—glaucoma	0.000149	0.000395	CcSEcCtD
Boceprevir—Headache—Bimatoprost—glaucoma	0.000149	0.000395	CcSEcCtD
Boceprevir—Nervous system disorder—Clonidine—glaucoma	0.000149	0.000394	CcSEcCtD
Boceprevir—Thrombocytopenia—Clonidine—glaucoma	0.000149	0.000394	CcSEcCtD
Boceprevir—Hypersensitivity—Dorzolamide—glaucoma	0.000148	0.000393	CcSEcCtD
Boceprevir—Tachycardia—Clonidine—glaucoma	0.000148	0.000392	CcSEcCtD
Boceprevir—Hypersensitivity—Travoprost—glaucoma	0.000148	0.000391	CcSEcCtD
Boceprevir—Skin disorder—Clonidine—glaucoma	0.000147	0.000391	CcSEcCtD
Boceprevir—Hyperhidrosis—Clonidine—glaucoma	0.000147	0.000389	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—C3—glaucoma	0.000146	0.000685	CbGpPWpGaD
Boceprevir—Visual impairment—Timolol—glaucoma	0.000146	0.000388	CcSEcCtD
Boceprevir—Malaise—Betaxolol—glaucoma	0.000146	0.000387	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—BCL2L1—glaucoma	0.000146	0.000683	CbGpPWpGaD
Boceprevir—Nausea—Apraclonidine—glaucoma	0.000146	0.000386	CcSEcCtD
Boceprevir—Hypersensitivity—Brinzolamide—glaucoma	0.000146	0.000386	CcSEcCtD
Boceprevir—Vertigo—Betaxolol—glaucoma	0.000145	0.000385	CcSEcCtD
Boceprevir—Syncope—Betaxolol—glaucoma	0.000145	0.000385	CcSEcCtD
Boceprevir—Dizziness—Acetazolamide—glaucoma	0.000145	0.000384	CcSEcCtD
Boceprevir—Asthenia—Dorzolamide—glaucoma	0.000144	0.000382	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—MMP1—glaucoma	0.000144	0.000673	CbGpPWpGaD
Boceprevir—Asthenia—Travoprost—glaucoma	0.000144	0.000381	CcSEcCtD
Boceprevir—Palpitations—Betaxolol—glaucoma	0.000143	0.000379	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—HDAC9—glaucoma	0.000143	0.000668	CbGpPWpGaD
Boceprevir—Pruritus—Dorzolamide—glaucoma	0.000142	0.000377	CcSEcCtD
Boceprevir—Loss of consciousness—Betaxolol—glaucoma	0.000142	0.000377	CcSEcCtD
Boceprevir—Eye disorder—Timolol—glaucoma	0.000142	0.000376	CcSEcCtD
Boceprevir—Asthenia—Brinzolamide—glaucoma	0.000142	0.000376	CcSEcCtD
Boceprevir—Hypotension—Clonidine—glaucoma	0.000142	0.000376	CcSEcCtD
Boceprevir—Pruritus—Travoprost—glaucoma	0.000142	0.000375	CcSEcCtD
Boceprevir—Tinnitus—Timolol—glaucoma	0.000142	0.000375	CcSEcCtD
Boceprevir—Cough—Betaxolol—glaucoma	0.000141	0.000374	CcSEcCtD
Boceprevir—Nausea—Bimatoprost—glaucoma	0.000141	0.000374	CcSEcCtD
Boceprevir—Cardiac disorder—Timolol—glaucoma	0.000141	0.000374	CcSEcCtD
Boceprevir—Hypersensitivity—Pilocarpine—glaucoma	0.00014	0.000371	CcSEcCtD
Boceprevir—Pruritus—Brinzolamide—glaucoma	0.00014	0.000371	CcSEcCtD
Boceprevir—Vomiting—Acetazolamide—glaucoma	0.00014	0.00037	CcSEcCtD
Boceprevir—Dizziness—Brimonidine—glaucoma	0.000139	0.000369	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Clonidine—glaucoma	0.000138	0.000366	CcSEcCtD
Boceprevir—Angiopathy—Timolol—glaucoma	0.000138	0.000365	CcSEcCtD
Boceprevir—Arthralgia—Betaxolol—glaucoma	0.000138	0.000365	CcSEcCtD
Boceprevir—Myalgia—Betaxolol—glaucoma	0.000138	0.000365	CcSEcCtD
Boceprevir—Chest pain—Betaxolol—glaucoma	0.000138	0.000365	CcSEcCtD
Boceprevir—Diarrhoea—Dorzolamide—glaucoma	0.000138	0.000365	CcSEcCtD
Boceprevir—Headache—Acetazolamide—glaucoma	0.000137	0.000364	CcSEcCtD
Boceprevir—Anxiety—Betaxolol—glaucoma	0.000137	0.000364	CcSEcCtD
Boceprevir—Insomnia—Clonidine—glaucoma	0.000137	0.000364	CcSEcCtD
Boceprevir—Immune system disorder—Timolol—glaucoma	0.000137	0.000364	CcSEcCtD
Boceprevir—Diarrhoea—Travoprost—glaucoma	0.000137	0.000363	CcSEcCtD
Boceprevir—Mediastinal disorder—Timolol—glaucoma	0.000137	0.000363	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000137	0.000363	CcSEcCtD
Boceprevir—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000137	0.000638	CbGpPWpGaD
Boceprevir—Asthenia—Pilocarpine—glaucoma	0.000136	0.000361	CcSEcCtD
Boceprevir—Paraesthesia—Clonidine—glaucoma	0.000136	0.000361	CcSEcCtD
Boceprevir—Discomfort—Betaxolol—glaucoma	0.000136	0.000361	CcSEcCtD
Boceprevir—Arrhythmia—Timolol—glaucoma	0.000136	0.00036	CcSEcCtD
Boceprevir—Dyspnoea—Clonidine—glaucoma	0.000135	0.000358	CcSEcCtD
Boceprevir—Diarrhoea—Brinzolamide—glaucoma	0.000135	0.000358	CcSEcCtD
Boceprevir—Dry mouth—Betaxolol—glaucoma	0.000135	0.000357	CcSEcCtD
Boceprevir—Pruritus—Pilocarpine—glaucoma	0.000134	0.000356	CcSEcCtD
Boceprevir—Alopecia—Timolol—glaucoma	0.000134	0.000356	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000134	0.000628	CbGpPWpGaD
Boceprevir—Confusional state—Betaxolol—glaucoma	0.000133	0.000353	CcSEcCtD
Boceprevir—Mental disorder—Timolol—glaucoma	0.000133	0.000353	CcSEcCtD
Boceprevir—Dizziness—Dorzolamide—glaucoma	0.000133	0.000352	CcSEcCtD
Boceprevir—Rash—Brimonidine—glaucoma	0.000133	0.000352	CcSEcCtD
Boceprevir—Dermatitis—Brimonidine—glaucoma	0.000133	0.000351	CcSEcCtD
Boceprevir—Dizziness—Travoprost—glaucoma	0.000132	0.000351	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—BAD—glaucoma	0.000132	0.000619	CbGpPWpGaD
Boceprevir—Erythema—Timolol—glaucoma	0.000132	0.00035	CcSEcCtD
Boceprevir—Malnutrition—Timolol—glaucoma	0.000132	0.00035	CcSEcCtD
Boceprevir—Headache—Brimonidine—glaucoma	0.000132	0.00035	CcSEcCtD
Boceprevir—Decreased appetite—Clonidine—glaucoma	0.000132	0.00035	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—MMP9—glaucoma	0.000131	0.000614	CbGpPWpGaD
Boceprevir—Infection—Betaxolol—glaucoma	0.000131	0.000348	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Clonidine—glaucoma	0.000131	0.000347	CcSEcCtD
Boceprevir—Fatigue—Clonidine—glaucoma	0.000131	0.000347	CcSEcCtD
Boceprevir—Dizziness—Brinzolamide—glaucoma	0.000131	0.000346	CcSEcCtD
Boceprevir—Nausea—Acetazolamide—glaucoma	0.00013	0.000345	CcSEcCtD
Boceprevir—Diarrhoea—Pilocarpine—glaucoma	0.00013	0.000345	CcSEcCtD
Boceprevir—Shock—Betaxolol—glaucoma	0.00013	0.000344	CcSEcCtD
Boceprevir—Constipation—Clonidine—glaucoma	0.00013	0.000344	CcSEcCtD
Boceprevir—Pain—Clonidine—glaucoma	0.00013	0.000344	CcSEcCtD
Boceprevir—Nervous system disorder—Betaxolol—glaucoma	0.00013	0.000343	CcSEcCtD
Boceprevir—Dysgeusia—Timolol—glaucoma	0.00013	0.000343	CcSEcCtD
Boceprevir—Thrombocytopenia—Betaxolol—glaucoma	0.000129	0.000343	CcSEcCtD
Boceprevir—Tachycardia—Betaxolol—glaucoma	0.000129	0.000342	CcSEcCtD
Boceprevir—Skin disorder—Betaxolol—glaucoma	0.000128	0.00034	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—GSTT1—glaucoma	0.000128	0.0006	CbGpPWpGaD
Boceprevir—Vomiting—Dorzolamide—glaucoma	0.000128	0.000339	CcSEcCtD
Boceprevir—Hyperhidrosis—Betaxolol—glaucoma	0.000128	0.000338	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—BAD—glaucoma	0.000127	0.000594	CbGpPWpGaD
Boceprevir—Rash—Dorzolamide—glaucoma	0.000127	0.000336	CcSEcCtD
Boceprevir—Dermatitis—Dorzolamide—glaucoma	0.000127	0.000336	CcSEcCtD
Boceprevir—Rash—Travoprost—glaucoma	0.000126	0.000335	CcSEcCtD
Boceprevir—Dermatitis—Travoprost—glaucoma	0.000126	0.000334	CcSEcCtD
Boceprevir—Headache—Dorzolamide—glaucoma	0.000126	0.000334	CcSEcCtD
Boceprevir—Vomiting—Brinzolamide—glaucoma	0.000126	0.000333	CcSEcCtD
Boceprevir—Dizziness—Pilocarpine—glaucoma	0.000126	0.000333	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—C3—glaucoma	0.000126	0.000587	CbGpPWpGaD
Boceprevir—Headache—Travoprost—glaucoma	0.000125	0.000332	CcSEcCtD
Boceprevir—Nausea—Brimonidine—glaucoma	0.000125	0.000331	CcSEcCtD
Boceprevir—Feeling abnormal—Clonidine—glaucoma	0.000125	0.000331	CcSEcCtD
Boceprevir—Rash—Brinzolamide—glaucoma	0.000125	0.00033	CcSEcCtD
Boceprevir—Vision blurred—Timolol—glaucoma	0.000125	0.00033	CcSEcCtD
Boceprevir—Dermatitis—Brinzolamide—glaucoma	0.000125	0.00033	CcSEcCtD
Boceprevir—Gastrointestinal pain—Clonidine—glaucoma	0.000124	0.000329	CcSEcCtD
Boceprevir—Headache—Brinzolamide—glaucoma	0.000124	0.000328	CcSEcCtD
Boceprevir—Hypotension—Betaxolol—glaucoma	0.000123	0.000327	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000123	0.000576	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1A—glaucoma	0.000122	0.00057	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1A—glaucoma	0.000122	0.00057	CbGpPWpGaD
Boceprevir—Angioedema—Timolol—glaucoma	0.000121	0.00032	CcSEcCtD
Boceprevir—Vomiting—Pilocarpine—glaucoma	0.000121	0.00032	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—C3—glaucoma	0.000121	0.000564	CbGpPWpGaD
Boceprevir—Urticaria—Clonidine—glaucoma	0.000121	0.000319	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00012	0.000319	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—BCL2L1—glaucoma	0.00012	0.000562	CbGpPWpGaD
Boceprevir—Body temperature increased—Clonidine—glaucoma	0.00012	0.000318	CcSEcCtD
Boceprevir—Abdominal pain—Clonidine—glaucoma	0.00012	0.000318	CcSEcCtD
Boceprevir—Rash—Pilocarpine—glaucoma	0.00012	0.000317	CcSEcCtD
Boceprevir—Dermatitis—Pilocarpine—glaucoma	0.00012	0.000317	CcSEcCtD
Boceprevir—Insomnia—Betaxolol—glaucoma	0.00012	0.000317	CcSEcCtD
Boceprevir—Nausea—Dorzolamide—glaucoma	0.000119	0.000317	CcSEcCtD
Boceprevir—Headache—Pilocarpine—glaucoma	0.000119	0.000315	CcSEcCtD
Boceprevir—Nausea—Travoprost—glaucoma	0.000119	0.000315	CcSEcCtD
Boceprevir—Vertigo—Timolol—glaucoma	0.000119	0.000315	CcSEcCtD
Boceprevir—Paraesthesia—Betaxolol—glaucoma	0.000119	0.000314	CcSEcCtD
Boceprevir—Syncope—Timolol—glaucoma	0.000119	0.000314	CcSEcCtD
Boceprevir—Dyspnoea—Betaxolol—glaucoma	0.000118	0.000312	CcSEcCtD
Boceprevir—Nausea—Brinzolamide—glaucoma	0.000117	0.000311	CcSEcCtD
Boceprevir—Palpitations—Timolol—glaucoma	0.000117	0.00031	CcSEcCtD
Boceprevir—Dyspepsia—Betaxolol—glaucoma	0.000116	0.000308	CcSEcCtD
Boceprevir—Loss of consciousness—Timolol—glaucoma	0.000116	0.000308	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000116	0.00054	CbGpPWpGaD
Boceprevir—Cough—Timolol—glaucoma	0.000115	0.000306	CcSEcCtD
Boceprevir—Decreased appetite—Betaxolol—glaucoma	0.000115	0.000304	CcSEcCtD
Boceprevir—Hypertension—Timolol—glaucoma	0.000114	0.000303	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Betaxolol—glaucoma	0.000114	0.000302	CcSEcCtD
Boceprevir—Fatigue—Betaxolol—glaucoma	0.000114	0.000302	CcSEcCtD
Boceprevir—Constipation—Betaxolol—glaucoma	0.000113	0.000299	CcSEcCtD
Boceprevir—Pain—Betaxolol—glaucoma	0.000113	0.000299	CcSEcCtD
Boceprevir—Nausea—Pilocarpine—glaucoma	0.000113	0.000299	CcSEcCtD
Boceprevir—Myalgia—Timolol—glaucoma	0.000113	0.000298	CcSEcCtD
Boceprevir—Arthralgia—Timolol—glaucoma	0.000113	0.000298	CcSEcCtD
Boceprevir—Chest pain—Timolol—glaucoma	0.000113	0.000298	CcSEcCtD
Boceprevir—Anxiety—Timolol—glaucoma	0.000112	0.000297	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SMO—glaucoma	0.000112	0.000523	CbGpPWpGaD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000112	0.000296	CcSEcCtD
Boceprevir—Hypersensitivity—Clonidine—glaucoma	0.000112	0.000296	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—MMP2—glaucoma	0.000111	0.00052	CbGpPWpGaD
Boceprevir—Discomfort—Timolol—glaucoma	0.000111	0.000295	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CDKN1B—glaucoma	0.000111	0.00052	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CDKN1B—glaucoma	0.000111	0.00052	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00011	0.000516	CbGpPWpGaD
Boceprevir—Dry mouth—Timolol—glaucoma	0.00011	0.000292	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—BAD—glaucoma	0.000109	0.000509	CbGpPWpGaD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000109	0.000509	CbGpPWpGaD
Boceprevir—Asthenia—Clonidine—glaucoma	0.000109	0.000288	CcSEcCtD
Boceprevir—Feeling abnormal—Betaxolol—glaucoma	0.000109	0.000288	CcSEcCtD
Boceprevir—Confusional state—Timolol—glaucoma	0.000109	0.000288	CcSEcCtD
Boceprevir—Pruritus—Clonidine—glaucoma	0.000107	0.000284	CcSEcCtD
Boceprevir—Infection—Timolol—glaucoma	0.000107	0.000284	CcSEcCtD
Boceprevir—CTSL—Immune System—C3—glaucoma	0.000107	0.000501	CbGpPWpGaD
Boceprevir—CTSV—Immune System—C3—glaucoma	0.000107	0.000501	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CDKN1B—glaucoma	0.000107	0.000499	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CDKN1B—glaucoma	0.000107	0.000499	CbGpPWpGaD
Boceprevir—Shock—Timolol—glaucoma	0.000106	0.000281	CcSEcCtD
Boceprevir—Nervous system disorder—Timolol—glaucoma	0.000106	0.00028	CcSEcCtD
Boceprevir—Urticaria—Betaxolol—glaucoma	0.000105	0.000278	CcSEcCtD
Boceprevir—Skin disorder—Timolol—glaucoma	0.000105	0.000278	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—BAD—glaucoma	0.000105	0.000489	CbGpPWpGaD
Boceprevir—Body temperature increased—Betaxolol—glaucoma	0.000104	0.000277	CcSEcCtD
Boceprevir—Hyperhidrosis—Timolol—glaucoma	0.000104	0.000276	CcSEcCtD
Boceprevir—Diarrhoea—Clonidine—glaucoma	0.000104	0.000275	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—FAS—glaucoma	0.000103	0.000482	CbGpPWpGaD
Boceprevir—CTSV—Immune System—BCL2L1—glaucoma	0.000103	0.00048	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BCL2L1—glaucoma	0.000103	0.00048	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NTRK2—glaucoma	0.000102	0.000478	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP1B1—glaucoma	0.000102	0.000478	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—C3—glaucoma	0.000102	0.000475	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1A—glaucoma	0.000101	0.000473	CbGpPWpGaD
Boceprevir—Hypotension—Timolol—glaucoma	0.000101	0.000267	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	0.000101	0.000471	CbGpPWpGaD
Boceprevir—Dizziness—Clonidine—glaucoma	0.0001	0.000266	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Timolol—glaucoma	9.83e-05	0.000261	CcSEcCtD
Boceprevir—Insomnia—Timolol—glaucoma	9.76e-05	0.000259	CcSEcCtD
Boceprevir—Hypersensitivity—Betaxolol—glaucoma	9.74e-05	0.000258	CcSEcCtD
Boceprevir—Paraesthesia—Timolol—glaucoma	9.69e-05	0.000257	CcSEcCtD
Boceprevir—Vomiting—Clonidine—glaucoma	9.65e-05	0.000256	CcSEcCtD
Boceprevir—Dyspnoea—Timolol—glaucoma	9.62e-05	0.000255	CcSEcCtD
Boceprevir—Rash—Clonidine—glaucoma	9.57e-05	0.000254	CcSEcCtD
Boceprevir—Dermatitis—Clonidine—glaucoma	9.56e-05	0.000253	CcSEcCtD
Boceprevir—Headache—Clonidine—glaucoma	9.51e-05	0.000252	CcSEcCtD
Boceprevir—Dyspepsia—Timolol—glaucoma	9.5e-05	0.000252	CcSEcCtD
Boceprevir—Asthenia—Betaxolol—glaucoma	9.48e-05	0.000251	CcSEcCtD
Boceprevir—Decreased appetite—Timolol—glaucoma	9.38e-05	0.000249	CcSEcCtD
Boceprevir—Pruritus—Betaxolol—glaucoma	9.35e-05	0.000248	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Timolol—glaucoma	9.32e-05	0.000247	CcSEcCtD
Boceprevir—Fatigue—Timolol—glaucoma	9.31e-05	0.000247	CcSEcCtD
Boceprevir—CTSV—Immune System—BAD—glaucoma	9.3e-05	0.000435	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BAD—glaucoma	9.3e-05	0.000435	CbGpPWpGaD
Boceprevir—Pain—Timolol—glaucoma	9.23e-05	0.000245	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CDKN1B—glaucoma	9.21e-05	0.000431	CbGpPWpGaD
Boceprevir—Diarrhoea—Betaxolol—glaucoma	9.04e-05	0.00024	CcSEcCtD
Boceprevir—Nausea—Clonidine—glaucoma	9.02e-05	0.000239	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—CA5A—glaucoma	8.99e-05	0.00042	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NARFL—glaucoma	8.99e-05	0.00042	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	8.99e-05	0.00042	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.95e-05	0.000418	CbGpPWpGaD
Boceprevir—Feeling abnormal—Timolol—glaucoma	8.9e-05	0.000236	CcSEcCtD
Boceprevir—CTSK—Immune System—C3—glaucoma	8.88e-05	0.000415	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CDKN1B—glaucoma	8.85e-05	0.000414	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Timolol—glaucoma	8.83e-05	0.000234	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NGFR—glaucoma	8.78e-05	0.00041	CbGpPWpGaD
Boceprevir—Dizziness—Betaxolol—glaucoma	8.74e-05	0.000231	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	8.7e-05	0.000407	CbGpPWpGaD
Boceprevir—Urticaria—Timolol—glaucoma	8.58e-05	0.000227	CcSEcCtD
Boceprevir—Abdominal pain—Timolol—glaucoma	8.53e-05	0.000226	CcSEcCtD
Boceprevir—Body temperature increased—Timolol—glaucoma	8.53e-05	0.000226	CcSEcCtD
Boceprevir—CTSK—Immune System—BCL2L1—glaucoma	8.5e-05	0.000398	CbGpPWpGaD
Boceprevir—Vomiting—Betaxolol—glaucoma	8.4e-05	0.000223	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NTRK1—glaucoma	8.34e-05	0.00039	CbGpPWpGaD
Boceprevir—Rash—Betaxolol—glaucoma	8.33e-05	0.000221	CcSEcCtD
Boceprevir—Dermatitis—Betaxolol—glaucoma	8.32e-05	0.000221	CcSEcCtD
Boceprevir—CTSS—Immune System—IL1A—glaucoma	8.32e-05	0.000389	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.32e-05	0.000389	CbGpPWpGaD
Boceprevir—Headache—Betaxolol—glaucoma	8.28e-05	0.000219	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—GSTM1—glaucoma	8.17e-05	0.000382	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	8.06e-05	0.000377	CbGpPWpGaD
Boceprevir—Hypersensitivity—Timolol—glaucoma	7.95e-05	0.000211	CcSEcCtD
Boceprevir—Nausea—Betaxolol—glaucoma	7.85e-05	0.000208	CcSEcCtD
Boceprevir—Asthenia—Timolol—glaucoma	7.74e-05	0.000205	CcSEcCtD
Boceprevir—CTSK—Immune System—BAD—glaucoma	7.7e-05	0.00036	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CDKN2B—glaucoma	7.69e-05	0.000359	CbGpPWpGaD
Boceprevir—Pruritus—Timolol—glaucoma	7.64e-05	0.000202	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CDKN1B—glaucoma	7.59e-05	0.000355	CbGpPWpGaD
Boceprevir—Diarrhoea—Timolol—glaucoma	7.39e-05	0.000196	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—EDN1—glaucoma	7.37e-05	0.000345	CbGpPWpGaD
Boceprevir—CTSS—Immune System—C3—glaucoma	7.31e-05	0.000342	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CDKN1B—glaucoma	7.29e-05	0.000341	CbGpPWpGaD
Boceprevir—Dizziness—Timolol—glaucoma	7.14e-05	0.000189	CcSEcCtD
Boceprevir—CTSS—Immune System—BCL2L1—glaucoma	7e-05	0.000327	CbGpPWpGaD
Boceprevir—Vomiting—Timolol—glaucoma	6.86e-05	0.000182	CcSEcCtD
Boceprevir—Rash—Timolol—glaucoma	6.81e-05	0.00018	CcSEcCtD
Boceprevir—Dermatitis—Timolol—glaucoma	6.8e-05	0.00018	CcSEcCtD
Boceprevir—ABCB1—Metabolism—CA5A—glaucoma	6.79e-05	0.000317	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NARFL—glaucoma	6.79e-05	0.000317	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NGF—glaucoma	6.78e-05	0.000317	CbGpPWpGaD
Boceprevir—Headache—Timolol—glaucoma	6.76e-05	0.000179	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	6.49e-05	0.000303	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDKN1B—glaucoma	6.48e-05	0.000303	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CDKN1B—glaucoma	6.48e-05	0.000303	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—C3—glaucoma	6.44e-05	0.000301	CbGpPWpGaD
Boceprevir—Nausea—Timolol—glaucoma	6.41e-05	0.00017	CcSEcCtD
Boceprevir—CTSS—Immune System—BAD—glaucoma	6.34e-05	0.000297	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—glaucoma	6e-05	0.00028	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	5.98e-05	0.00028	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.97e-05	0.000279	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CAV1—glaucoma	5.94e-05	0.000278	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	5.94e-05	0.000278	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	5.89e-05	0.000276	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FN1—glaucoma	5.66e-05	0.000264	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—BAD—glaucoma	5.59e-05	0.000261	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.55e-05	0.00026	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDKN1B—glaucoma	5.37e-05	0.000251	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—glaucoma	5.1e-05	0.000239	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	5.08e-05	0.000238	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.75e-05	0.000222	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.69e-05	0.000219	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOS3—glaucoma	4.49e-05	0.00021	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDKN1B—glaucoma	4.42e-05	0.000207	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CA1—glaucoma	4.39e-05	0.000205	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—glaucoma	4.37e-05	0.000205	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.35e-05	0.000203	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CTSA—glaucoma	4.25e-05	0.000199	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NARFL—glaucoma	4.18e-05	0.000195	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA5A—glaucoma	4.18e-05	0.000195	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.06e-05	0.00019	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CA2—glaucoma	4.02e-05	0.000188	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CDKN1B—glaucoma	3.89e-05	0.000182	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.8e-05	0.000178	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.75e-05	0.000175	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—glaucoma	3.61e-05	0.000169	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CA1—glaucoma	3.31e-05	0.000155	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—glaucoma	3.24e-05	0.000151	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CTSA—glaucoma	3.21e-05	0.00015	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.2e-05	0.00015	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CA2—glaucoma	3.03e-05	0.000142	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.03e-05	0.000142	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TXN—glaucoma	2.83e-05	0.000132	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.52e-05	0.000118	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—glaucoma	2.45e-05	0.000114	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTT1—glaucoma	2.19e-05	0.000103	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.16e-05	0.000101	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TXN—glaucoma	2.14e-05	9.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA1—glaucoma	2.04e-05	9.55e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CTSA—glaucoma	1.98e-05	9.25e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.9e-05	8.9e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA2—glaucoma	1.87e-05	8.73e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1B1—glaucoma	1.75e-05	8.18e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCA1—glaucoma	1.75e-05	8.18e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTT1—glaucoma	1.66e-05	7.74e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—glaucoma	1.4e-05	6.54e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1B1—glaucoma	1.32e-05	6.17e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCA1—glaucoma	1.32e-05	6.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TXN—glaucoma	1.32e-05	6.15e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—glaucoma	1.24e-05	5.78e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—glaucoma	1.15e-05	5.38e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAV1—glaucoma	1.14e-05	5.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—glaucoma	1.05e-05	4.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTT1—glaucoma	1.02e-05	4.77e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—glaucoma	9.32e-06	4.36e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—glaucoma	8.68e-06	4.06e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—glaucoma	8.62e-06	4.03e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAV1—glaucoma	8.6e-06	4.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCA1—glaucoma	8.13e-06	3.8e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1B1—glaucoma	8.13e-06	3.8e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—glaucoma	7.88e-06	3.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—glaucoma	6.5e-06	3.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—glaucoma	6.5e-06	3.04e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—glaucoma	5.95e-06	2.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—glaucoma	5.74e-06	2.69e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—glaucoma	5.35e-06	2.5e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAV1—glaucoma	5.3e-06	2.48e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—glaucoma	4.01e-06	1.87e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—glaucoma	3.66e-06	1.71e-05	CbGpPWpGaD
